Efficacy of Bioceramic Materials for Bone Defects Repair

Launched by NANJING FIRST HOSPITAL, NANJING MEDICAL UNIVERSITY · Jan 31, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of special bioceramic materials to help repair bone defects, which can occur due to various conditions like bone fractures, arthritis, or bone loss. The researchers want to see how effective these bioceramic implants are in helping bones heal faster and better. They believe that by carefully designing the surface of these implants, they can encourage the body to regenerate bone more effectively, which could be very helpful for patients dealing with bone-related issues.

To participate in the trial, individuals must be between 18 and 65 years old and must be able to communicate and follow instructions during the study. They should not have any serious allergies or health conditions that might complicate the trial, such as severe heart or lung problems. Participants who join the study will likely undergo procedures involving the bioceramic implants and will be monitored for their recovery. This research is important as it could lead to improved treatments for people with bone problems and enhance their quality of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients who voluntarily take the test and sign the informed consent form;
• • 2. Patients aged 18-65 years old with no history of allergies;
• • 3. Patients able to communicate well with the investigator and follow the requirements of the entire trial.
• Exclusion Criteria:
• • 1. Patients who refuse to sign the informed consent form to participate in the trial;
• • 2. Patients who are not in the age range of 18 to 65 years;
• • 3. Patients with diseases unsuitbale for the trial: history of allergies, severe cardiopulmonary disease, coagulation dysfunction, Alzheimer's disease, cerebral atrophy, acute phase or sequelae of cerebrovascular disease, cognitive impairment;
• • 4. Patients in the acute phase of local or systemic bacterial infections;
• • 5. Patients who cannot cooperate with the operation and evaluate the effect;
• • 6. Other conditions that are considered inappropriate by the investigator to participate in the study.